Drug Trial News

RSS
Trial shows safety and tolerability of antisense oligomer for treatment of influenza A

Trial shows safety and tolerability of antisense oligomer for treatment of influenza A

Combination treatment improves progression-free survival in patients with advanced urothelial cancer

Combination treatment improves progression-free survival in patients with advanced urothelial cancer

Study: New oral drug helps control glucose, reduces need for insulin in patients with type 1 diabetes

Study: New oral drug helps control glucose, reduces need for insulin in patients with type 1 diabetes

Insmed reports top-line data from Phase 3 study of new treatment in patients with NTM lung disease

Insmed reports top-line data from Phase 3 study of new treatment in patients with NTM lung disease

Tulane University researchers develop new drug effective against malaria

Tulane University researchers develop new drug effective against malaria

New medication shows potential to reduce fracture risk in women with osteoporosis

New medication shows potential to reduce fracture risk in women with osteoporosis

Antibody therapy found effective in subgroup of patients with treatment-resistant COPD

Antibody therapy found effective in subgroup of patients with treatment-resistant COPD

Australian researchers make ultimate move in the battle against melanoma

Australian researchers make ultimate move in the battle against melanoma

Combination therapy found to be effective adjuvant treatment option in melanoma patients

Combination therapy found to be effective adjuvant treatment option in melanoma patients

Combination immunotherapy as second or third line treatment of mesothelioma shows promising results

Combination immunotherapy as second or third line treatment of mesothelioma shows promising results

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Study: Immunotherapy shows promising response rate in patients with metastatic gastric cancer

Study: Immunotherapy shows promising response rate in patients with metastatic gastric cancer

Two new treatments may benefit patients with high risk prostate cancer, trial shows

Two new treatments may benefit patients with high risk prostate cancer, trial shows

New trial confirms superiority of triplet regimen over standard care in resectable esophago-gastric cancer

New trial confirms superiority of triplet regimen over standard care in resectable esophago-gastric cancer

LORELEI trial: Treatment with alpha specific PI3K inhibitor reduces breast tumor size

LORELEI trial: Treatment with alpha specific PI3K inhibitor reduces breast tumor size

Eli Lilly to lay off 8.5 percent of employees in bid to cut costs

Eli Lilly to lay off 8.5 percent of employees in bid to cut costs

Study finds long-term effectiveness of HPV vaccine in preventing cervical cancer

Study finds long-term effectiveness of HPV vaccine in preventing cervical cancer

New trial examines whether compound given before and after bypass surgery mitigates cognitive deficits

New trial examines whether compound given before and after bypass surgery mitigates cognitive deficits

New drug shows promise to treat women with estrogen positive metastatic breast cancer

New drug shows promise to treat women with estrogen positive metastatic breast cancer

First-in-class investigational drug lowers LDL cholesterol for up to one year, study finds

First-in-class investigational drug lowers LDL cholesterol for up to one year, study finds